ALEMBIC PHARMA Fact Sheet, ALEMBIC PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Fact Sheet    (APLL)


Discover: India's #1 Defence Stock


Here is the latest financial fact sheet of ALEMBIC PHARMA. For more details, see the ALEMBIC PHARMA quarterly results and ALEMBIC PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALEMBIC PHARMA Price History

Price Rs 996.7
Mkt Cap Rs m 187,898
Vol '000 24.4
P/E X 17.9
P/CF X 26.5
EPS (TTM) Rs 55.7
% ch % 0.9
No. of shares m 188.52
% ch week % 2.4
% ch 1-mth % 4.0
% ch 12-mth % 79.6
52 week H/L Rs 1,128.0/436.1
(As on Nov 27, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALEMBIC PHARMA Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
ALEMBIC PHARMA EQUITY SHARE DATA
High Rs495792709645664 
Low Rs228443516470412 
Sales per share (Unadj.) Rs109.1167.0166.3166.1208.7 
Earnings per share (Unadj.) Rs15.038.221.421.931.0 
Diluted earnings per shareRs15.038.221.421.931.0 
Cash flow per share (Unadj.) Rs17.442.025.827.537.1 
Dividends per share (Unadj.) Rs3.504.004.004.005.50 
Adj. dividends per shareRs3.504.004.004.005.50 
Dividend yield (eoy) %1.00.60.70.71.0 
Book value per share (Unadj.) Rs46.984.9100.9117.8144.2 
Adj. book value per shareRs46.984.9100.9117.8144.2 
Shares outstanding (eoy) m188.52188.52188.52188.52188.52 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x3.33.73.73.42.6 
Avg P/E ratio x24.116.228.625.517.4 
P/CF ratio (eoy) x20.814.723.820.314.5 
Price / Book Value ratio x7.77.36.14.73.7 
Dividend payout %23.310.518.718.317.7 
Avg Mkt Cap Rs m68,122116,383115,459105,090101,461 
No. of employees `000NANANANANA 
Total wages/salary Rs m3,0684,2145,5886,2287,467 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ALEMBIC PHARMA INCOME DATA
Net Sales Rs m20,56131,48731,34631,30839,347 
Other income Rs m2355207094 
Total revenues Rs m20,58431,54231,36631,37839,441 
Gross profit Rs m4,03010,0606,1536,4318,736 
Depreciation Rs m4447228301,0551,152 
Interest Rs m18375234184 
Profit before tax Rs m3,5919,3565,2915,4137,493 
Minority Interest Rs m000011 
Prior Period Items Rs m2-2-38-81-93 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m7642,1601,2221,2041,568 
Profit after tax Rs m2,8297,1944,0314,1285,844 
Gross profit margin %19.631.919.620.522.2 
Effective tax rate %21.323.123.122.220.9 
Net profit margin %13.822.812.913.214.9 
ALEMBIC PHARMA BALANCE SHEET DATA
Current assets Rs m8,90715,06613,72518,24719,577 
Current liabilities Rs m6,8417,6746,92711,23514,896 
Net working cap to sales %10.123.521.722.411.9 
Current ratio x1.32.02.01.61.3 
Inventory Days Days6867748690 
Debtors Days Days6441396145 
Net fixed assets Rs m5,9478,23711,95720,03527,097 
Share capital Rs m377377377377377 
"Free" reserves Rs m8,37415,41618,64621,82426,811 
Net worth Rs m8,84616,00519,02322,20127,188 
Long term debt Rs m188005,0004,993 
Total assets Rs m16,41224,59426,89339,41147,778 
Interest coverage x202.7255.2102.2160.241.7 
Debt to equity ratio x0000.20.2 
Sales to assets ratio x1.31.31.20.80.8 
Return on assets %17.329.415.210.612.6 
Return on equity %32.044.921.218.621.5 
Return on capital %40.058.727.919.723.6 
Exports to sales %39.355.749.846.40 
Imports to sales %10.010.410.310.50 
Exports (fob) Rs m8,08517,55115,62614,5350 
Imports (cif) Rs m2,0503,2833,2413,2880 
Fx inflow Rs m8,28417,81115,80614,72219,453 
Fx outflow Rs m3,1475,3185,2897,0266,065 
Net fx Rs m5,13712,49310,5177,69613,388 
ALEMBIC PHARMA CASH FLOW
From Operations Rs m 1,718 9,304 3,286 3,124 8,120 
From Investments Rs m -2,556 -3,105 -4,859 -8,844 -7,556 
From Financial Activity Rs m 867 -1,959 -1,289 5,026 590 
Net Cashflow Rs m 29 4,240 -2,862 -693 1,153 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.1%
Foreign collaborators 0.0%
Indian inst/Mut Fund 2.9%
FIIs 9.1%
ADR/GDR 0.0%
Free float 13.9%
Shareholders 49,328
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Alembic Road, ,Vadodara,Gujarat - 390 003
E-MAIL apl.investors@alembic.co.in WEB www.alembic-india.com
TELEPHONE (0265) 2282 550 FAX (0265) 2282 506
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, B-102-103, Shangrila Complex, Akota, Vadodara-20
AUDITOR K. S. Aiyar & Co.
CHM: Chirayu R. Amin (MD) COMP SEC: Rajkumar Baheti YEAR OF INC: 2010 BSE CODE: 533573 FV (Rs): 2 DIV YIELD (%): 0.6

Read: ALEMBIC PHARMA 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   INDOCO REMEDIES  FRESENIUS KABI ONCO.  AUROBINDO PHARMA  NATCO PHARMA  FULFORD INDIA  

Compare ALEMBIC PHARMA With:   INDOCO REMEDIES  FRESENIUS KABI ONCO.  AUROBINDO PHARMA  NATCO PHARMA  FULFORD INDIA  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends 110 Points Lower; Smallcap & Midcap Stocks Outperform(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower, ahead of Q2 GDP data.

Views on news

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

Stocks that Could Shine More than Gold After Diwali (Profit Hunter)

Nov 17, 2020

If the markets become volatile over the next few months, do this.

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

How to Build the Best Trading System (Fast Profits Daily)

Nov 20, 2020

In this video, I'll show you how to make the best trading system.

An Eraser and Some Pencils (The Honest Truth)

Nov 17, 2020

Ajit Dayal on the road ahead for the world after covid.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS